#24 - Tom Dayspring, M.D., FACP, FNLA Part V of V: Lp(a), inflammation, oxLDL, remnants, and more

Published: Oct. 19, 2018, 9:30 a.m.

b'

In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter\'s most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part V, Peter and Tom talk about inflammation, endothelial health, and oxidative stress as they pertain to cardiovascular disease, and our attempts to monitor them using biomarkers. They also discuss a couple of very important risk factors that too few people (and doctors) know about. Tom closes the five-part series with a tragic story about his good friend that is likely all-too-common for many practicing physicians, that both haunts and motivates Dr. Dayspring to learn as much as he can about the number one killer in the United States.

We discuss:

  • \\xa0\\xa0\\xa0 Lp(a) [2:30];
  • \\xa0\\xa0\\xa0 Inflammation [17:15];
  • \\xa0\\xa0\\xa0 Oxidative stress markers: Lp-PLA2 and oxLDL [20:45];
  • \\xa0\\xa0\\xa0 Endothelial health markers: ADMA and SDMA [34:30];
  • \\xa0\\xa0\\xa0 Remnants [43:45];
  • \\xa0\\xa0\\xa0 Omega-3 fatty acids (EPA and DHA) and apoC-III [55:30];
  • \\xa0\\xa0\\xa0 Red blood cells and cholesterol transport [1:07:45];
  • \\xa0\\xa0\\xa0 Tom\'s friend Earl [1:10:00];
  • \\xa0\\xa0\\xa0 Peter\'s friend JP [1:18:15]; and
  • \\xa0\\xa0\\xa0 More.

Learn more at\\xa0www.PeterAttiaMD.com

Connect with Peter on Facebook | Twitter | Instagram.

'